Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1989-7-24
|
pubmed:abstractText |
Human T cell clones were prepared from peripheral blood mononuclear cells from a vaccinated human donor and kept in culture in the presence of rabies virus antigen and growth factors. Phenotypic analysis of the T cell clones revealed expression of the CD3 and CD4 cell surface markers, but not of CD8, consistent with a phenotype of helper/inducer T cells. The rabies virus specificity of the T cell clones was established by virus-specific proliferation in response to the rabies virus Pitman-Moore strain (PM) produced in three different cell substrates. The clones also responded to the rabies virus strains Evelyn-Rokitnicki-Abelseth (ERA) and challenge virus standard (CVS), but not to the rabies virus-related Mokola and Duvenhage-6 virus strains. Proliferative responses of T cell clones required rabies virus antigen to be presented by autologous antigen-presenting cells in association with HLA class II molecules. When cultured with rabies virus antigen, but in the absence of growth factors, some of the T cell clones provided help for an antibody response of rabies virus immune B lymphocytes. Analysis of culture supernatant fluids showed that at least a part of this antibody response was directed against neutralizing antibody-inducing determinants of the viral glycoprotein.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Rabies Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-1317
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70 ( Pt 6)
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1513-21
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2471814-Antibodies, Viral,
pubmed-meshheading:2471814-Antigens, Viral,
pubmed-meshheading:2471814-Binding, Competitive,
pubmed-meshheading:2471814-Clone Cells,
pubmed-meshheading:2471814-Epitopes,
pubmed-meshheading:2471814-Glycoproteins,
pubmed-meshheading:2471814-Humans,
pubmed-meshheading:2471814-Major Histocompatibility Complex,
pubmed-meshheading:2471814-Neutralization Tests,
pubmed-meshheading:2471814-Phenotype,
pubmed-meshheading:2471814-Rabies Vaccines,
pubmed-meshheading:2471814-Rabies virus,
pubmed-meshheading:2471814-T-Lymphocytes, Helper-Inducer,
pubmed-meshheading:2471814-Viral Proteins
|
pubmed:year |
1989
|
pubmed:articleTitle |
Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein.
|
pubmed:affiliation |
National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
|
pubmed:publicationType |
Journal Article
|